date:Mar 21, 2013
ore noteworthy because it was made despite a competing offer for Complete Genomics by Illumina Inc, a San Diego company that is BGI-Shenzhen's major supplier of sequencing machines.
Doug Schenkel, an analyst with Cowen Co in Boston, suggested in September that Illumina's higher bid of $123.5 million was aimed at blocking BGI-Shenzhen's pending purchase of Complete Genomics. The Chinese company, he said, was interested in reducing its dependence on Illumina.
Complete Genomics ultimately reject